跳至主要内容
临床试验/NCT03371212
NCT03371212进行中(未招募)4 期

A Prospective Randomized Trial of Modular Dual Mobility Acetabular Components Versus Conventional Single Bearing Components in Primary Total Hip Arthroplasty

Rush University Medical Center1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2017年12月15日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
52
试验地点
1
主要终点
Serum cobalt levels, measures cobalt level in the serum in ug/L

研究概览

简要总结

The aim of this study is to determine if the use of a modular dual mobility bearing is associated with clinically important increases in serum metal levels.

详细描述

Prosthetic dislocation following total hip arthroplasty (THA) remains a significant concern with a reported incidence of 0.2%-7.0% after primary and 10%-25% after revision THA. The risk of dislocation following THA is multifactorial and includes both surgeon-related factors (i.e. component positioning, surgical approach) and patient-related factors (i.e. gender, age). Dual mobility articulations have been shown to reduce the incidence of hip instability following THA. Dual mobility implants have been used in Europe for over 30 years, but have recently received an increased interest in the United States.

Initial dual mobility designs consisted of a cementless, monoblock acetabular component with a highly-polished metal inner bearing surface. Modular dual mobility prostheses have been introduced in which a modular cobalt-alloy liner is inserted into a hemispherical titanium acetabular component. Advantages of this construct include familiarity of use of a standard titanium acetabular component and the ability to use supplemental screw fixation. However, the potential for fretting corrosion between the cobalt-alloy liner and the titanium acetabular component remains a concern.

In a retrospective review of 100 consecutive patients undergoing primary THA using a modular dual mobility prosthesis, the authors found 21% of patients to have a serum cobalt level above the normal range, with 9% significantly above normal (> 1.6 ug/L), at a mean of 27.6 months postoperatively. In addition, a recent prospective cohort study of 26 patients receiving the same prosthesis showed elevated whole blood mean cobalt levels in patients receiving a modular dual mobility prosthesis versus patients receiving a conventional bearing (0.23 + 0.39 vs. 0.15 + 0.07ug/L, p<0.001) at 1 year postoperatively. Four patients in the dual mobility cohort had a whole blood cobalt level outside the reference range (maximum 1.81 ug/L).

To the investigators knowledge no prospective, randomized controlled trial has been performed comparing dual mobility bearings to a conventional single-bearing design. Therefore, the purpose of this study is to compare the use of a conventional single-bearing ceramic-on-polyethylene surface to use of a modular dual mobility bearing in a prospective, randomized controlled setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

The patient will not have information about the treatment group they've been assigned to until after surgery.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age between 18 and 80 years
  • •Willingness to undergo serial postoperative venipuncture for serum meal analysis
  • •BMI < 40
  • •Patients that are eligible for the requisite implants as deemed by their surgeon

排除标准

  • •Clinically significant systemic chronic disease
  • •Diminished renal function
  • •Presence of any metal-containing implant outside of the oral cavity
  • •History of prior hip surgery involving an internal fixation device
  • •History of hip infection
  • •Preoperative diagnosis other than osteoarthritis
  • •Anticipated need for another joint replacement surgery within one year
  • •Patients taking chromium supplements

研究组 & 干预措施

Conventional Cohort

Active Comparator

Patients in this group will receive a Taperloc femoral stem, ceramic femoral head (size 32mm for acetabular components 48/50mm; size 36mm for acetabular components > 52mm), polyethylene bearing, and G7 acetabular shell.

干预措施: Conventional cohort (Device)

Modular Dual Mobility Cohort

Experimental

Patients in this group will receive a Taperloc femoral stem, inner ceramic femoral head (28mm), mobile polyethylene bearing, cobalt alloy liner, and G7 acetabular shell.

干预措施: Dual mobility cohort (Device)

结局指标

主要结局

Serum cobalt levels, measures cobalt level in the serum in ug/L

时间窗: up to 5 years

Assays for each subject for serum cobalt in ug/L

Serum chromium levels, measures chromium level in the serum in ug/L

时间窗: up to 5 years

Assays for each subject for serum chromium in ug/L

Serum titanium levels, measures titanium level in the serum in ug/L

时间窗: up to 5 years

Assays for each subject for serum titanium in ug/L

次要结局

  • Patient reported outcome measures (survey) for the Harris Hip Score(up to 5 years)
  • Patient reported outcome measures (survey) for SF-12 score.(up to 5 years)
  • Patient reported outcome measures (survey) for the SANE score.(up to 5 years)
  • Patient reported outcome measures (survey) for the UCLA activity score.(up to 5 years)
  • Patient reported outcome measures (survey) for the Hoos Jr. score.(up to 5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验